Profile
Sector:
HealthcareCountry:
Hong KongIPO:
16 July 2021Next earnings report:
20 June 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:39:37 GMTDividend
Analysts recommendations
Institutional Ownership
RGC Latest News
ROANOKE, Va., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO), at its meeting on September 30, 2024, declared a quarterly dividend of $0.20 per share on the Company's common stock. The dividend will be paid on November 1, 2024 to shareholders of record on October 18, 2024. This is the Company's 322nd consecutive quarterly cash dividend.
ROANOKE, Va., Aug. 05, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated Company earnings of $156,692, or $0.02 per share, for the third quarter ended June 30, 2024, compared to $686,816, or $0.07 per share, for the fiscal quarter ended June 30, 2023. The decline was the result of decreased operating income due to higher personnel and professional costs as well as persistent inflationary pressures across most areas compared to a year ago, along with lower noncash earnings from the Company's investment in the Mountain Valley Pipeline, LLC (“MVP”) as the pipeline transitioned from construction to gas transmission operations.
ROANOKE, Va., July 26, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal third quarter 2024 on Wednesday, August 7, 2024 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at https://www.rgcresources.com/investor-financial-information/ .
What type of business is Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
What sector is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited is in the Healthcare sector
What industry is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited is in the Drug Manufacturers - Specialty & Generic industry
What country is Regencell Bioscience Holdings Limited from?
Regencell Bioscience Holdings Limited is headquartered in Hong Kong
When did Regencell Bioscience Holdings Limited go public?
Regencell Bioscience Holdings Limited initial public offering (IPO) was on 16 July 2021
What is Regencell Bioscience Holdings Limited website?
https://www.regencellbioscience.com
Is Regencell Bioscience Holdings Limited in the S&P 500?
No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index
Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index
Is Regencell Bioscience Holdings Limited in the Dow Jones?
No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index
When was Regencell Bioscience Holdings Limited the previous earnings report?
No data
When does Regencell Bioscience Holdings Limited earnings report?
The next expected earnings date for Regencell Bioscience Holdings Limited is 20 June 2025